Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/09/057238
CTRI/2023/09/057238
Completed
未知

Exploratory study of immune response in different Agni participantsin University examination stress - NI

DR AKANKSHA D SHIRPURKAR0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
DR AKANKSHA D SHIRPURKAR
Enrollment
30
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 21, 2024
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
DR AKANKSHA D SHIRPURKAR

Eligibility Criteria

Inclusion Criteria

  • •Individuals from both sexes.
  • •Participants between 18\-25 yrs of age.
  • •Participants having no history of co morbidities and gastrointestinal problems.
  • •Not taking any medications from past 6 months.

Exclusion Criteria

  • •Individuals involved in regular sports or yoga.
  • •Individuals engaged in any kind of stress management measures.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
The study to compare the immune response between intradermal and intramuscular injection of botulinum toxin AHealthy human volunteersEnzyme-Linked Immunosorbent Assay, Botulinum Toxins, Immunoglobulins, Antibodies
TCTR20211204002Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand100
Completed
Not Applicable
Study of immune parameters that may differ between HC and patients with MS : an explorative studyMSMultiple Sclerosis1000381610007951
NL-OMON37483School for Mental Health and Neuroscience100
Active, not recruiting
Not Applicable
A Clinical trial to analysis of immune profile following neoadjuvant chemotherapy in colorectal liver metastases patientsNeoplasms
KCT0003474Asan Medical Center20
Not yet recruiting
Phase 4
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunizatio
CTRI/2017/02/007793Panacea Biotec Ltd800
Not yet recruiting
Not Applicable
Study of host immune response in patients of fungal infection of skin.Health Condition 1: B356- Tinea cruris
CTRI/2019/09/021297Indian Association of Dermatologists Venereologists and Leprologists